Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × ER+ Breast Cancer × Tamoxifen × Clear all

Phase

Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 9 Sexuality 1 Patient Acceptance of Health Care 1 Mastodynia 1 Fibrocystic Breast Disease 1 Fibroadenoma 1 ER+ Breast Cancer 1 Cystic Fibrosis 1 Breast Carcinoma In Situ 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05525481 2023-11-01

PREDICTAM

Erasmus Medical Center

Phase 4 Unknown

ER+ Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡